/NXEN
NXEN Stock - Nexien BioPharma, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NXEN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.97
52W High$0.02
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-156,000 | $-283,000 | $-340,737 | $-750,100 | $-2,637,000 |
| Net Income | $-239,000 | $-362,000 | $-626,000 | $-1,860,000 | $-2,672,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.01 | $-0.01 | $-0.03 | $-0.05 |
Company Overview
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NXENBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q4 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Nov 17, 2025 | — | — | — | — |
Q2 2025 | May 14, 2025 | — | $-0.00 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 18, 2024 | — | $-0.00 | — | — |
Q4 2024 | Oct 22, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 20, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 17, 2023 | — | $1313.05 | — | — |
Q1 2023 | Feb 8, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 9, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 28, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 12, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 8, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.00 | — | — |
Q4 2021 | Oct 12, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 5, 2021 | — | $0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NXEN
What is NXEN's current stock price?
Nexien BioPharma, Inc. (NXEN) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for NXEN?
No analyst price targets are currently available for this stock.
What sector is Nexien BioPharma, Inc. in?
Nexien BioPharma, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is NXEN's market cap?
Nexien BioPharma, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NXEN pay dividends?
No, Nexien BioPharma, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUS
Acusphere, Inc.
$0.00
Mkt Cap: $0.0B
AQSZF
Aequus Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
DVLP
Golden Developing Solutions, Inc.
$0.00
Mkt Cap: $0.0B
IRBS
IR Biosciences Holdings Inc.
$0.00
Mkt Cap: $0.0B
IVIXF
Invion Limited
$0.04
Mkt Cap: $0.0B
MCIC
MultiCorp International, Inc.
$0.00
Mkt Cap: $0.0B
NEPTF
Neptune Wellness Solutions Inc.
$0.00
Mkt Cap: $0.0B
RGMP
Regnum Corp.
$0.00
Mkt Cap: $0.0B
TSTS
That Marketing Solution, Inc.
$0.00
Mkt Cap: $0.0B
XTXXF
Adastra Holdings Ltd.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to NXEN for comparison